Cargando…
Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
BACKGROUND: Enhancer dysregulation is one of the important features for cancer cells. Enhancers enriched with H3K4me3 have been implicated to play important roles in cancer. However, their detailed features and regulatory mechanisms have not been well characterized. RESULTS: Here, we profile the lan...
Autores principales: | Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680327/ https://www.ncbi.nlm.nih.gov/pubmed/38012744 http://dx.doi.org/10.1186/s13059-023-03108-3 |
Ejemplares similares
-
Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment
por: Zhou, Cefan, et al.
Publicado: (2016) -
H3K4me2 Promotes the Activation of lncCPSET1 by Jun in the Chicken PGC Formation
por: Zhang, Chen, et al.
Publicado: (2021) -
Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes
por: Zheng, Yongxin, et al.
Publicado: (2021) -
H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development
por: Jang, Younghoon, et al.
Publicado: (2019) -
Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia
por: Richter, William F, et al.
Publicado: (2021)